Literature DB >> 8213366

[The long term results of hyperbaric oxygen treatment for macular edema with retinal vein occlusion].

H Miyamoto1, Y Ogura, Y Wakano, Y Honda.   

Abstract

We retrospectively evaluated the effect of hyperbaric oxygen treatment on seventy-nine eyes of seventy cases with cystoid macular edema secondary to retinal vein occlusion. Twenty-three eyes had central retinal vein occlusion (CRVO), and fifty-six eyes had branch retinal vein occlusion (BRVO). Visual acuity improved by two lines or more in 40 eyes (17%) with BRVO, and in 10 eyes (44%) with CRVO immediately after the therapy. Six months or more after treatment, visual improvement persisted in 14 of 30 BRVO eyes (47%), and in only one of 11 CRVO eyes (9%). CRVO showed poor prognosis in the long term compared with BRVO. We speculated that activation of aerobic metabolism might be more important than reduction of vascular hyperpermeability as the therapeutic effect of hyperbaric oxygen, and that hyperbaric oxygen might mainly affect the retinal cells in the marginal zone of the ischemic retina in the macular region.

Entities:  

Mesh:

Year:  1993        PMID: 8213366

Source DB:  PubMed          Journal:  Nippon Ganka Gakkai Zasshi        ISSN: 0029-0203


  3 in total

1.  Systemic oxygen therapy versus oral enalapril for treatment of diabetic macular ischemia: a randomized controlled trial.

Authors:  Farideh Sharifipour; Mohammadreza Razzaghi; Alireza Ramezani; Mohsen Azarmina; Mehdi Yaseri; Roham Soheilian; Masoud Soheilian
Journal:  Int Ophthalmol       Date:  2015-08-21       Impact factor: 2.031

2.  Vitreal oxygenation in retinal ischemia reperfusion.

Authors:  Walid Abdallah; Hossein Ameri; Ernesto Barron; Gerald J Chader; Elias Greenbaum; David R Hinton; Mark S Humayun
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-22       Impact factor: 4.799

Review 3.  Oxygen therapy and ophthalmology.

Authors:  Des Gorman
Journal:  Oman J Ophthalmol       Date:  2013-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.